| dc.contributor.author |
Karaoui, Lamis |
|
| dc.contributor.author |
Tawil, Samah |
|
| dc.date.accessioned |
2016-09-30T07:29:18Z |
|
| dc.date.available |
2016-09-30T07:29:18Z |
|
| dc.date.copyright |
2011 |
en_US |
| dc.date.issued |
2016-09-30 |
|
| dc.identifier.issn |
0090-3493 |
en_US |
| dc.identifier.uri |
http://hdl.handle.net/10725/4464 |
|
| dc.language.iso |
en |
en_US |
| dc.title |
Efficacy and Safety of Enoxaparin 20 Mg Subcutaneously in Patients With Chronic Kidney Disease Stages 4 and 5 for Deep Vein Thrombosis Prophylaxis |
en_US |
| dc.type |
Article |
en_US |
| dc.description.version |
Published |
en_US |
| dc.author.school |
SOP |
en_US |
| dc.author.idnumber |
200101817 |
en_US |
| dc.author.department |
Pharmacy Practice |
en_US |
| dc.description.embargo |
N/A |
en_US |
| dc.relation.journal |
Critical Care Medicine |
en_US |
| dc.journal.volume |
39 |
en_US |
| dc.journal.issue |
12 |
en_US |
| dc.article.pages |
225 |
en_US |
| dc.identifier.doi |
http://dx.doi.org/10.1097/01.ccm.0000408627.24229.88 |
en_US |
| dc.identifier.ctation |
Karaoui, L., & Tawil, S. (2011). Efficay and safety of Enoxaparin 20 mg subcutaneously in patients with chronic kidney disease stages 4 and 5 for deep vein thrombosis prophylaxis. Critical Care Medicine, 39(12), 225. |
en_US |
| dc.author.email |
lamis.karaoui@lau.edu.lb |
en_US |
| dc.identifier.tou |
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php |
en_US |
| dc.identifier.url |
https://journals.lww.com/ccmjournal/Fulltext/2011/12001/801__EFFICACY_AND_SAFETY_OF_ENOXAPARIN_20_MG.757.aspx |
en_US |
| dc.orcid.id |
https://orcid.org/0000-0002-7857-7374 |
|